Rua Bioscience Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Public

  • Employees
  • 24

Employees

  • Stock Symbol
  • RUA

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.01
  • (As of Tuesday Closing)

Rua Bioscience General Information

Description

Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, with its primary business being research and development and the sale of pharmaceutical products in New Zealand, Australia, and Europe.

Contact Information

Website
www.ruabio.com
Formerly Known As
Hikurangi Cannabis Company
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Gisborne
  • New Zealand
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NZE
Vertical(s)
Corporate Office
  • Gisborne
  • New Zealand

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rua Bioscience Stock Performance

As of 17-Nov-2026, Rua Bioscience’s stock price is $0.01. Its current market cap is $5.42M with 379M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $0.01 $0.01 - $0.02 $5.42M 379M 87.6K

Rua Bioscience Financials Summary

As of 30-Jun-2026, Rua Bioscience has a trailing 12-month revenue of $1.51M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 5,170 5,170 4,035 3,341
Revenue 1,509 1,509 890 52
EBITDA (1,559) (1,559) (1,704) (8,139)
Net Income (1,964) (1,964) (2,034) (8,315)
Total Assets 4,052 4,052 4,115 4,711
Total Debt 992 992 488 90
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Rua Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rua Bioscience‘s full profile, request access.

Request a free trial

Rua Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rua Bioscience Acquisitions (1)

Rua Bioscience’s most recent deal was a Merger/Acquisition with Zalm Therapeutics for . The deal was made on 19-Jan-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Zalm Therapeutics 19-Jan-2022 Merger/Acquisition Personal Products
To view Rua Bioscience’s complete acquisitions history, request access »

Rua Bioscience ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Traders & Distributors

Industry

Rank

Percentile

Trading and Distribution

Subindustry

Rank

Percentile

To view Rua Bioscience’s complete esg history, request access »

Rua Bioscience FAQs

  • When was Rua Bioscience founded?

    Rua Bioscience was founded in 2016.

  • Where is Rua Bioscience headquartered?

    Rua Bioscience is headquartered in Gisborne, New Zealand.

  • What is the size of Rua Bioscience?

    Rua Bioscience has 24 total employees.

  • What industry is Rua Bioscience in?

    Rua Bioscience’s primary industry is Drug Discovery.

  • Is Rua Bioscience a private or public company?

    Rua Bioscience is a Public company.

  • What is Rua Bioscience’s stock symbol?

    The ticker symbol for Rua Bioscience is RUA.

  • What is the current stock price of Rua Bioscience?

    As of 17-Nov-2026 the stock price of Rua Bioscience is $0.01.

  • What is the current market cap of Rua Bioscience?

    The current market capitalization of Rua Bioscience is $5.42M.

  • What is Rua Bioscience’s current revenue?

    The trailing twelve month revenue for Rua Bioscience is $1.51M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process